Adipocyte-Derived Versican and Macrophage-Derived Biglycan Control Adipose Tissue Inflammation in Obesity
Chang Yeop Han(University of Washington), Alan Chait(University of Washington), Shari Wang(University of Washington), Diego Gomes Kjerulf(University of Washington), Christina K. Chan(Virginia Mason Medical Center), Thomas N. Wight(Benaroya Research Institute), John A. Gebe(Matrix Research (United States)), Kimberly M. Alonge(University of Washington), Mohamed Omer(University of Washington), Savitha Subramanian(Gates Foundation), Leela Goodspeed(University of Washington), Francis Kim(I.R.C.C.S. Oasi Maria SS), David E. Birk(University of South Florida), Inkyung Kang(Matrix Research (United States)), Ingrid A. Harten(Matrix Research (United States)), Laura J. den Hartigh(University of Washington)
Cited by 62
Related Papers
Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis
|Hepatology|2012|293
Versican—A Critical Extracellular Matrix Regulator of Immunity and Inflammation
|Frontiers in Immunology|2020|264
Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice
|Journal of Lipid Research|2011|242
Genetic Evidence for the Coordinated Regulation of Collagen Fibrillogenesis in the Cornea by Decorin and Biglycan
|Journal of Biological Chemistry|2009|228
Hypertriglyceridemia secondary to obesity and diabetes
|Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids|2011|200